Alira Health’s COVID-19 Response

News
Published on:
April 4, 2020

Throughout the COVID-19 pandemic, the Alira Health team has worked closely with our partners throughout the healthcare ecosystem to help support the community and get resources into the hands of those that need it most. Our work includes:

Just-in-time regulatory support

Our regulatory team, led by Mary McNamara-Cullinane, has been working closely with our clients and FDA on several fronts, including:

  • One Emergency Use Authorization to wean patients off ventilators is pending at FDA
  • Two ventilator accessory Emergency Use Authorizations
  • One remote patient monitoring system Emergency Use Authorization
  • Additional Emergency Use Authorizations for disinfectants and sanitizers are currently pendin

In addition, Mary is on two national task forces providing regulatory guidance for respirator and mask manufacturers.

Mary McNamara-Cullinane

Led by David Uffer, Senior Partner and VP of MedTech and Deepak Sahu, Partner, the Alira Health team has worked closely with partners across the healthcare ecosystem to provide:

Support across the supply chain

  • Supply chain reinforcement by connecting hospitals, suppliers, and governments to critical resources, including PPE and ventilators.
  • Support in establishing a PPE factory in India by connecting funding and technology with regional officials. This factory has been scaling up to produce more than 100,000 pairs of gloves and gowns.
  • Collaboration with the CEO of a Massachusetts hospital to connect the hospital’s innovation center with manufacturing partners for PPE technologies.
David Uffer

Analysis and operational assistance

  • Introductions of an N95 respirator technology to potential manufacturers and investors.
  • Partnership with experienced industry professionals (who developed HIV screening protocols) to develop COVID-19 screening protocols. Looking past the current crisis, the team is also looking at how screening should be considered long-term.
  • Helping a low-cost ventilator company to scale up. The company is connected with several Massachusetts universities and has seen positive clinical results.
Deepak Sahu

If you need help with your own COVID-19 relief work, please contact us to discuss how we can help support your efforts.

Related news

MedTech
Events August 8, 2021
Event: BIOMEDevice Panel Session
Carlo Stimamiglio, Partner at Alira Health will speak on the panel, My CDMO Has Been Acquired - Now What? on Tuesday September 21, 2021.
MedTech
Multimedia August 6, 2021
Alira Health’s Transformation Talks: Overcoming Challenges to Reimbursement in Robotic Surgery for the French Market
Our latest Alira Health Transformation Talks is all about Robotic Surgery.
MedTech
Events August 5, 2021
Event: The MedTech Conference
Join the Alira Health team at AdvaMed September 29-30, 2021 in Minneapolis, MN.
MedTech
News July 27, 2021
Alira Health Announces it Role as Strategic Advisor to Montagu Private Equity
We are pleased to have advised Montagu PE in the acquisition of Intech, a target active in the design and manufacturing of complex reusable surgical instrumentation for Minimal Invasive(...)
MedTech
News July 22, 2021
Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head
We are pleased to announce that Fredrik Nyberg has joined Alira Health as Partner and Regional Head
Regulatory
Events July 20, 2021
Webinar Recap: Risk Management & Regulatory Submissions
Download Alira Health's Senior Vice President, Regulatory Affairs, Mary McNamara-Cullinane's webinar presentation, How to Implement Risk Management into Regulatory Submissions Using(...)
Regulatory
Publications July 20, 2021
Infographic: The Pre-IND to Market Approval Roadmap in the U.S.
Download our latest infographic, The Pre-IND to Market Approval Roadmap in the U.S.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.